T1	Participants 52 127	postmenopausal women with advanced, hormone-receptor-positive breast cancer
T2	Participants 464 517	patients with hormone-receptor-positive breast cancer
T3	Participants 602 743	postmenopausal women with hormone-receptor-positive, locally advanced or metastatic breast cancer previously treated with endocrine treatment
T4	Participants 1437 1478	We screened 189 patients and enrolled 156
T5	Participants 2501 2601	women with previously treated hormone-receptor-positive locally advanced or metastatic breast cancer
